PMID- 11099466 OWN - NLM STAT- MEDLINE DCOM- 20010208 LR - 20231213 IS - 0892-6638 (Print) IS - 0892-6638 (Linking) VI - 14 IP - 15 DP - 2000 Dec TI - High-efficiency transient transfection of endothelial cells for functional analysis. PG - 2486-94 AB - The definition of signaling pathways in endothelial cells has been hampered by the difficulty of transiently transfecting these cells with high efficiency. This investigation was undertaken to develop an efficient technique for the transfection of endothelial cells for functional analyses. Cells cotransfected with plasmid expressing green fluorescent protein (GFP) and the plasmid of interest were isolated by fluorescence-activated cell sorting (FACS) based on GFP expression. In the sorted cell population, a 2.5-fold enhancement in the number of cells expressing the gene of interest was observed, as confirmed by FACS analysis and Western blotting. Sorted cells retained functional properties, as demonstrated by chemotaxis to the agonist sphingosine 1-phosphate (SPP). To demonstrate the usefulness of this method for defining cellular signaling pathways, cells were cotransfected with plasmids encoding GFP and the carboxyl-terminal domain of the beta-adrenergic receptor kinase (beta ARKct), which inhibits signaling through the beta gamma dimer of heterotrimeric G-proteins. SPP-induced chemotaxis in sorted cells coexpressing beta ARKct was inhibited by 80%, demonstrating that chemotaxis was driven by a beta gamma-dependent pathway. However, no significant inhibition was observed in cells transfected with betaARKct but not enriched by sorting. Thus, we have developed a method for enriching transfected cells that allows the elucidation of crucial mechanisms of endothelial cell activation and function. This method should find wide applicability in studies designed to define pathways responsible for regulation of motility and other functions in these dynamic cells. FAU - Kovala, A T AU - Kovala AT AD - Experimental Cell Research Program, Methodist Research Institute, Clarian Health Partners, Inc., Indianapolis, Indiana 46202, USA. FAU - Harvey, K A AU - Harvey KA FAU - McGlynn, P AU - McGlynn P FAU - Boguslawski, G AU - Boguslawski G FAU - Garcia, J G AU - Garcia JG FAU - English, D AU - English D LA - eng GR - P01 HL 50864/HL/NHLBI NIH HHS/United States GR - R01 61751/PHS HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Luminescent Proteins) RN - 0 (Recombinant Fusion Proteins) RN - 147336-22-9 (Green Fluorescent Proteins) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - EC 2.7.11.15 (beta-Adrenergic Receptor Kinases) RN - EC 3.6.5.1 (Heterotrimeric GTP-Binding Proteins) SB - IM MH - Animals MH - Aorta MH - Cattle MH - Cell Separation MH - Chemotaxis/*genetics MH - Cyclic AMP-Dependent Protein Kinases/*genetics/metabolism MH - *Endothelium, Vascular MH - Green Fluorescent Proteins MH - Heterotrimeric GTP-Binding Proteins/metabolism MH - Luminescent Proteins/genetics MH - Recombinant Fusion Proteins/metabolism MH - Signal Transduction MH - Transfection/*methods MH - beta-Adrenergic Receptor Kinases MH - Red Fluorescent Protein EDAT- 2000/12/02 11:00 MHDA- 2001/03/03 10:01 CRDT- 2000/12/02 11:00 PHST- 2000/12/02 11:00 [pubmed] PHST- 2001/03/03 10:01 [medline] PHST- 2000/12/02 11:00 [entrez] AID - 14/15/2486 [pii] AID - 10.1096/fj.00-0147com [doi] PST - ppublish SO - FASEB J. 2000 Dec;14(15):2486-94. doi: 10.1096/fj.00-0147com.